Clinical Trial Update: Memantine Therapy for Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating memantine for multiple sclerosis has been terminated. Sponsored by Clinica Universidad de Navarra and Universidad de Navarra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Multiple Sclerosis | Phase 2 | Status: TERMINATED